Gerald Simonneau, MD, PhD, is Emeritus Professor at the Université Paris-Saclay, France. He founded the French national reference centre for pulmonary hypertension in 2004, which he then led between 2004 and 2016, at the Antoine Béclère hospital, and then later at the Kremlin Bicetre hospital (Assistance Publique-Hopitaux de Paris and Paris-Saclay university).
His research career focused initially on intensive care and acute pulmonary embolism, then dedicated his research to pulmonary hypertension, with a first publication in the New Engl J Med in 1981 (G Simonneau et al. Inhibition of hypoxic pulmonary vasoconstriction by Nifedipine). He has received several international distinctions, among them the ERS lifetime Achievement in pulmonary vascular diseases in 2020.
He has published widely in the fields of pulmonary hypertension, pulmonary embolism and intensive care in peer-reviewed journals including New England Journal of Medicine, The Lancet, Circulation, JACC, Eur Respir J, and Eur Heart J. Clarivate Analytics listed Gerald Simonneau as one of the world’s most highly cited researchers in the field of clinical medicine for 2018, 2019 and 2020 and 2021. In 2022, his h-index in the Google Scholar Citations database was 147 (134,533 citations).
Gérald was co-chair of the 4th, 5th, and 6th ERS World Congress on Pulmonary Hypertension held in 2008, 2013, and 2018.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)